Delay in filling clopidogrel prescription after coronary stent linked to adverse clinical outcomes

News
Article

A delay in filling the first prescription for clopidogrel after coronary stenting is associated with an increased risk of death and myocardial infarction (MI), according to a study published online May 28 in the Journal of the American Heart Association.

A delay in filling the first prescription for clopidogrel after coronary stenting is associated with an increased risk of death and myocardial infarction (MI), according to a study published online May 28 in the Journal of the American Heart Association.

Researcher Nicholas L. Cruden, PhD, and colleagues conducted a retrospective, data linkage study in British Columbia who had a coronary artery stent implanted from 2004 to 2007. They wanted to investigate the effect of a delay in filling a first clopidogrel prescription after hospital discharge on clinical outcomes following coronary stenting.

Of 15,629 patients treated with coronary stents, 3,599 received at least 1 drug-eluting stent (DES) and 12,030 received bare-metal stents alone.

“Thirty percent of patients failed to fill a prescription for clopidogrel within 3 days of hospital discharge,” Cruden said. “Delay in filling a first community prescription for clopidogrel was associated with a 5-fold increase in mortality and 3-fold increase in risk of MI in first 30 days following discharge after percutaneous coronary intervention [PCI] procedures.”

The findings highlight the importance of ensuring adherence/compliance with antiplatelet therapy post-PCI and the need to address barriers (geographical, financial, social, etc.) to patients obtaining prescriptions, according to Cruden.

“We know that premature discontinuation/interruption of clopidogrel post-PCI is associated with adverse events, the risk of stent thrombosis/reinfarction greatest in 30 days after PCI, and this coincides with the time when patients transition from hospital to home and frequently have difficulties with medication compliance,” he said.

 

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.